Skip to main content

Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back

Objective

Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE will bring together modeling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE will take into consideration clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum and eventually increase resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
BOUNCE will deliver a unified clinical model of modifiable factors associated with optimal disease outcomes and will deploy a prospective multi-center clinical pilot at four major oncology centers (in Italy, Finland, Israel and Portugal), where a total of 660 women will be recruited in order to assess its clinical validity against crucial patient outcomes (illness progression, wellbeing, and functionality). The advanced computational tools to be employed will validate indices of patients’ capacity to bounce back during the highly stressful treatment and recovery period following diagnosis of breast cancer. The overreaching goal of BOUNCE is to incorporate elements of a dynamic, predictive model of patient outcomes in building a decision-support system used in routine clinical practice to provide physicians and other health professionals with concrete, personalized recommendations regarding optimal psychosocial support strategies.

Call for proposal

H2020-SC1-2016-2017

See other projects for this call

Sub call

H2020-SC1-2017-CNECT-2

Coordinator

HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ
Net EU contribution
€ 795 625,00
Address
Stenbackinkatu 9
00029 Helsinki
Finland
Activity type
Research Organisations
Non-EU contribution
€ 0,00
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa

Participants (8)

IDRYMA TECHNOLOGIAS KAI EREVNAS
Greece
Net EU contribution
€ 726 875,00
Address
N Plastira Str 100
70013 Irakleio
Activity type
Research Organisations
Non-EU contribution
€ 0,00
Region
Ηράκλειο Κρήτη Νησιά Αιγαίου
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy
Net EU contribution
€ 375 600,00
Address
Via Filodrammatici 10
20121 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Greece
Net EU contribution
€ 487 500,00
Address
Patission Str. 42
10682 Athina
Activity type
Research Organisations
Non-EU contribution
€ 0,00
Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
NHG FINLAND OY
Finland
Net EU contribution
€ 747 435,00
Address
Vattuniemenranta 2
00210 Helsinki
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
 
THE HEBREW UNIVERSITY OF JERUSALEM
Israel
Net EU contribution
€ 557 000,00
Address
Edmond J Safra Campus Givat Ram
91904 Jerusalem
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
SINGULARLOGIC ANONYMI ETAIREIA PLIROFORIAKON SYSTIMATON KAI EFARMOGONPLIROFORIKIS
Greece
Net EU contribution
€ 448 125,00
Address
Achaias 3 & Troizinias
14564 Nea Kifisia
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Βόρειος Τομέας Αθηνών Aττική Αττική
FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD
Portugal
Net EU contribution
€ 497 000,00
Address
Avenida Brasilia, Centro De Investigacao Da Fundacao Champalimaud
1400-038 Lisboa
Activity type
Research Organisations
Non-EU contribution
€ 0,00
Region
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
VARIAN MEDICAL SYSTEMS FINLAND OY
Finland
Net EU contribution
€ 364 250,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Paciuksenkatu 21
00270 Helsinki
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00